Geneo
- Company typePrivate
- Founded-
- HeadquartersNewport Beach, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Geneo does
Geneo United LLC, doing business as Glo2Facial, develops and commercializes the Geneo X aesthetic device platform, a multi-modality professional facial system that combines four technology modules: RF Pro (multipolar radio frequency cleared by FDA for use by licensed estheticians), Oxfoliation (a patented exfoliation-and-oxygenation process that activates the body's Bohr Effect), Lite Ultrasound (serum infusion via micro-vibrations), and Detox (hands-free circulation massage). The system is sold with proprietary OxyPods and serums that target eight skin concerns (Brighten, Clarify, Energize, ExoFirm, Hydrate, Protect, Refine, Smooth) and is used across face and body indications including chest, back, arms, bikini, butt, and legs. The brand was previously known as OxyGeneo and was rebranded to Glo2Facial in May 2023, with RF Pro introduced in 2022.
The company operates a B2B razor/blade model: the Geneo X hardware is placed with US-based med spas, dermatology practices, plastic surgery centers, day spas, beauty salons, and licensed estheticians through a direct field sales motion, with ownership paths that include Lease2Own ($999-$1,099/month for 24 months with bundled consumables), 0% interest financing for 36 months, and outright cash purchase. Recurring revenue is generated by the requirement that providers purchase proprietary OxyPods and serums for every treatment, with reported provider economics of $200 average profit per treatment and 80-95% gross margins on consumables. A Provider Locator tool connects end consumers to certified locations, and a Digital Academy plus multi-city live events support onboarding and retention.
Geneo is a privately held subsidiary of Lumenis, a global leader in energy-based solutions for aesthetic and vision applications, providing R&D, regulatory, and distribution backing. The company is headquartered in Newport Beach, California with a Salt Lake City support and sales office, is concentrated in the US market, and has built brand visibility through coverage in Cosmopolitan, ELLE, Vogue, Forbes, USA Today, RealSelf, Byrdie, PopSugar, and Elite Daily, plus celebrity endorsements including Paris Hilton.
Geneo firmographics
Firmographics- Name
- Geneo
- Legal name
- Geneo United LLC
- Website
- https://glo2facial.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Where Geneo is headquartered
LocationHeadquarters
- HQ city
- Newport Beach
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Geneo business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations
Revenue model
- Geneo X Device Sales/Leasing: Geneo X device sold through Lease2Own (24-month program at $999/month or $1,099/month with RF Pro), traditional financing (0% interest for 36 months), or cash purchase. Device generates recurring consumable revenue as providers must purchase proprietary OxyPods and serums for each treatment.
- Consumables (OxyPods and Serums): Ongoing consumable purchases required for each treatment. The Lease2Own program includes 2 boxes of consumables (12 treatments) per month. Treatment customizations include Brighten, Clarify, Energize, ExoFirm, Hydrate, Protect, Refine, and Smooth capsules.
- Professional Treatment Services: Providers generate revenue from performing treatments on end consumers. With $200 average profit per treatment and high-profit margins of 80-95% on consumables, med spas and estheticians can achieve strong ROI.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Lease2Own - Device Only |
| Subscription | Monthly | Lease2Own - With RF Pro |
| Subscription | Multi-year contract | Traditional Financing |
| One time/ perpetual license | Pay-as-you-go | Cash Purchase |
| Unit Pricing | Pay-as-you-go | Treatment Economics |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels8 records
Geneo product offering
Product offeringCore offering
Geneo manufactures and sells the Geneo X professional aesthetic device to med spas, dermatology practices, and licensed estheticians, who use it to deliver the Glo2Facial treatment. The device combines four proprietary technologies (RF Pro, Oxfoliation, Ultrasound, Detox) in a single treatment, with revenue generated by one-time device sales or leases and by recurring consumable purchases of OxyPods and serums required for each session.
Product overview
Geneo offers the Glo2Facial treatment system, a comprehensive skincare platform consisting of the Geneo X professional device and multiple treatment technologies. The core Glo2Facial treatment combines four proprietary technology modules—RF Pro (radio frequency), Oxfoliation (oxygenation/exfoliation), Ultrasound (serum infusion), and Detox (circulation massage)—delivered through the Geneo X hardware device. Treatments are customized through interchangeable OxyPods and serums targeting specific skin concerns: Brighten, Clarify, Energize, ExoFirm, Hydrate, Protect, Refine, and Smooth. The system is designed for use by licensed estheticians in med spas, dermatology practices, and beauty salons, with no downtime required for patients.
Differentiator
Problem solved
Functional benefit
Brands
- Geneo X: Professional facial device used for Glo2Facial treatments, available for purchase by licensed estheticians and med spas.
- RF Pro
- Oxfoliation
- Glo2Facial Provider Shop
Quantifiable outcome
- 400% revenue growth reported by Vela Aesthetics in first year after introducing Glo2Facial
- +4 more outcomes
Companies that use Geneo
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles1 record
Geneo technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Geneo partnerships and signals
Strategic signalScale indicators4 records
Recent moves3 records
Expansion highlights6 records
Geneo competitors and assessment
Company assessmentDirect peers
- Venus Concept: Venus Concept offers energy-based devices (Venus Versa, Venus Legacy, Venus Viva) plus a subscription/lease business model aimed at med spas and aesthetic practices. The lease-plus-consumables model and customer base closely mirror Geneo's Lease2Own approach.
- Alma Lasers: Alma offers multi-technology platforms (Accent, Soprano, Harmony) combining RF, ultrasound, and other modalities into medical aesthetic practices globally, competing head-to-head with Glo2Facial on combination treatment positioning and price points.
- Cutera: Cutera sells multi-modality energy-based aesthetic platforms (Secret RF, truSculpt, Excel V) into dermatology and med spa practices, directly overlapping with Geneo's RF and ultrasound offerings. Both compete for the same dermatology and med spa capital equipment budgets.
- InMode: InMode's Morpheus8 (RF microneedling) and BodyTite platforms are widely adopted in med spas and dermatology offices, competing directly with RF Pro for the same collagen-stimulation, skin-remodeling patient indications Geneo targets.
- Sciton: Sciton manufactures aesthetic and dermatology laser/RF platforms (BBL, Halo, Profractional) sold into high-end med spas and dermatology clinics. It competes for the same capital equipment purchases and treatment menu real estate as Geneo X.
- Edge Systems / HydraFacial: HydraFacial is the leading multi-step hydradermabrasion facial device sold into med spas and esthetician practices through a similar B2B-plus-consumables (serums/booster) model. It is the most direct head-to-head competitor to Geneo X's Glo2Facial platform in the same customer base.
- Solta Medical (Bausch Health): Solta markets Thermage (RF skin tightening), Fraxel, and Clear+Brilliant into the same dermatologist/med spa channel as Geneo, with similar treatment economics and consumable/service revenue dynamics. Direct competitor on the RF skin rejuvenation angle.
Emerging players
- Cartessa Aesthetics: Cartessa is a US-focused aesthetic device distributor specializing in premium, results-driven technologies for med spas and dermatology offices. It partners with emerging device manufacturers in much the same US channel where Geneo sells Glo2Facial devices, representing a partial-overlap emerging competitor/distributor dynamic.
Broad incumbents
- Cynosure (Hologic): Cynosure is a large, broad-line energy-based aesthetics incumbent with RF, laser, and body-contouring devices sold into the same med spa and dermatology channels as Geneo. It competes as a multi-portfolio incumbent rather than a single-platform specialist.
- BTL Aesthetics: BTL produces non-invasive aesthetic platforms (Emsculpt, Emface, Exilis) widely used in med spas and dermatology practices. While focused on body and facial muscle/tissue toning, it competes for the same B2B capital budget and end-consumer treatment slot within provider offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Geneo social profiles
Digital presenceGeneo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Geneo leadership team
Management profileNumber of profiles
Geneo funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Geneo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Geneo
What does Geneo do?
Geneo manufactures and sells the Geneo X professional aesthetic device to med spas, dermatology practices, and licensed estheticians, who use it to deliver the Glo2Facial treatment. The device combines four proprietary technologies (RF Pro, Oxfoliation, Ultrasound, Detox) in a single treatment, with revenue generated by one-time device sales or leases and by recurring consumable purchases of OxyPods and serums required for each session.
Is Geneo a public or private company?
Geneo is a private company. It is currently operating.
When was Geneo founded?
Geneo was founded in -1. It employs 51 to 100 people.
Where is Geneo based?
Geneo is headquartered in Newport Beach, United States, in the North America region.
How does Geneo make money?
Three revenue lines are on record. Geneo X Device Sales/Leasing is the primary driver. The others are consumables (OxyPods and Serums) and professional Treatment Services.
Who are Geneo's main competitors?
Direct peers on record are Venus Concept, Alma Lasers, Cutera, InMode, Sciton, Edge Systems / HydraFacial and Solta Medical (Bausch Health). Cartessa Aesthetics is listed as an emerging player. Broad incumbents are Cynosure (Hologic) and BTL Aesthetics.
Does Geneo have an API?
No public API is recorded for Geneo.